Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TW001 food-effect and pharmacokinetic crossover pilot in ALS
NL-OMON42324Active, not recruiting
- Sponsor
- Treeway
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of TW001 in amyotrophic lateral sclerosis (ALS), sponsored by Treeway. Primary endpoints: Pharmacokinetic profile of single-dose TW001, Effect on oxidative stress parameters and 1 more. Started May 2015; status: active, not recruiting.
02
Drugs
TW001
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NL-OMON42324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42324.